← Leaderboards
Max W Sung
Mount Sinai School Of Medicine Of Cuny
$770,200
Attributed
$770,200
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $143.2K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$770,200 · 8
By mechanism
M01$431,200 · 7
R21$339,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Cuny
Same institution · by research overlap
- Simon J Hall$47,556
- George F Atweh$3,209,628
- Helen Vlassara$10,094,910
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyClinical ResearchCombination Cancer TherapyHuman SubjectAdenoviridaeClinical Trial Phase IGanciclovirThymidine KinaseMetastasisHuman Therapy EvaluationNeoplasm /Cancer ChemotherapyColorectal NeoplasmsTransfection /Expression VectorAlphaherpesvirinaeCessation Of LifeAdenovirus VectorCancer EtiologyInstitutionColorectal CancerFundingClinical TrialsBaseCytokineAnimals
Grant awards (14)
CLINICAL TRIAL: ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTERLEUKIN-12 CDNA IN M$25,691
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTERLEUKIN-12 CDNA IN M$21,688
M01 · FY2008 · RR · contact PI
TRIAL OF HUMAN INTERLEUKIN-12 CDNA IN METASTATIC COLORECTAL CANCER TO THE LIVER$82,669
M01 · FY2007 · RR · contact PI
PHASE I TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTERLEUKIN-12 CDNA$87,936
M01 · FY2006 · RR · contact PI
PHASE I TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTERLEUKIN-12 CDNA$55,227
M01 · FY2006 · RR · contact PI
PHASE I TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTELEUKIN-12 CDNA B$22,951
M01 · FY2005 · RR
CLINICAL TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HERPES THYMIDINE KINASE ($603
M01 · FY2005 · RR
Phase I Trial of Adenoviral Vector Delivery of the Human Inteleukin-12 cDNA b...$45,829
M01 · FY2004 · RR
Clinical Trial of Adenoviral vector Delivery of the Herpes Thymidine Kinase (...$19,818
M01 · FY2004 · RR
COMBINATION GENE THERAPY IN COLORECTAL CANCER$169,500
R21 · FY2003 · CA
PHASE I TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HERPES SIMPLEX THYMIDINE$0
M01 · FY2002 · RR
PHASE I TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HERPES SIMPLEX THYMIDINE$0
M01 · FY2001 · RR
COMBINATION GENE THERAPY IN COLORECTAL CANCER$169,500
R21 · FY2000 · CA
PHASE I TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HERPES SIMPLEX THYMIDINE$68,788
M01 · FY2000 · RR